stock trade discount merg
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research sep
estim sep
price data sep
rate updat sep
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
strategi past decad one
ever-increas emphasi healthcar oper
de-emphasize less moatworthi insur busi
culmin compani merger express script
late give top-tier presenc pharmaci
without risk think strateg rational sound combin
medic pharmaceut benefit right move
past hand year integr peer appear
price product advantag pure-play rival
expect transact help win busi
combin benefit offer improv sticki
relationship given pbm industri standard three-year
howev steep price paid polit vulner asset
cusp lose largest client mean investor
particularli keen ensur manag remain track
expect laid combin entiti view
ep target provid achiev
beatabl real perceiv weak perform
segment come year like met
skeptic particularli true given govern focu
alter current price paradigm drug suppli chain
includ recent scrap move chang rebat practic
on-going reform effort look like direct neg
pbm broadli specif size impact pbm
expect dialogu around broad healthcar reform pick
come quarter elect cycl loom near
believ largest peer develop
econom moat durabl enough weather storm
rel low likelihood widespread industri disrupt
opportun privat insur continu part solut
suggest us posit earn excess econom
return next year
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
long leader self-fund employ health insur market cigna
expand reach organ recent merger
express script firm oper par peer
medic pharmaceut benefit capabl help level
play field year come addit firm leader
accid disabl life insur global although busi
becom much less import overal enterpris express
script merger expand healthcar offer
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
leav fair valu estim unchang
per share impli roughli time
time estim adjust earn ebitda
assum abl grow health insur roll
roughli annual help continu strength
among employ client improv posit
line low- mid-single-digit cost trend
modest increas medic loss ratio time lead
declin oper margin firm health
insur busi take account
loss firm pharmaci benefit segment
assum total claim overal price roughli flat
addit assum oper
profit per claim busi declin toward
averag line peer lead cumul
declin oper margin roughli basi point
forecast period
combin forecast result overal revenu growth
averag midsingl digit consolid adjust
ebitda margin nearli basi point annual
said combin debt reduct
share repurchas allow ep grow near
compound-annual-growth-rate next five year
given increas risk associ integr
express script loss largest custom
increas regulatori scrutini pbm profit give
neg mix associ government-sponsor
enrol growth segment margin declin limit
roughli basi point total
firm pbm segment expect total claim
slightli higher follow loss
price set expand compound
annual growth rate period instanc
assum segment oper margin remain roughli flat
compani abl maintain best-in-class per-script
profit assumpt result fair valu
estim per share roughli time
time adjust earn ebitda forecast
bear-cas assumpt presum compani expand
medic insur roll annual
forecast period govern employer-sponsor
busi under-perform base expect margin
pressur instanc remain particularli acut
termin net margin compani health insur
busi nearli substanti
approxim averag sinc compani
pbm segment assum overal script count remain
level seen loss unit
price declin basi point annual averag
five-year forecast period addit assum
elev expens result per-script profit fall
peer overal expect firm
base forecast final year model
scenario result fair valu estim per share
roughli time adjust earn
ebitda forecast respect
bull-cas scenario assum firm grow
medic membership roughli annual come
five year mid-single-digit cost trend assumpt
continu expect modest margin pressur
deserv narrow econom moat rate given
scale stand-alon health insur also reflect
combin express script give
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
top measur membership given sizabl
exposur self-fund arrang think
provid firm enough scale deriv durabl
competit advantag root cost advantag
along network effect believ present
among largest insur player advantag
thought two way relat back size
insur book busi first larger membership
base allow greater central fixed-cost leverag
increas profit potenti margin member
overal enterpris second larger membership base
allow greater negoti leverag versu provid
insur need creat attract plan network
difficult directli measur financi
perform book busi versu peer
approxim commerci client choos
self-fund program think firm consist
membership growth signifi valu bring
tabl firm posit enrol growth
fee-bas commerci busi year sinc least
among managed-car organ
cover addit manag suggest boast
lowest commerci cost trend past sever year
among larg peer part like due
firm sizabl invest behind get member
medic cost tie value-bas arrang
collabor arrang physician group
specialist compani abl drive nearli
spend altern payment arrang
primari market help align incent
payer provid particularli true
self-fund arrang plan sponsor directli
benefit lower-than-anticip growth medic
also believ insur organ like benefit
network effect believ common
among larg health plan network effect also play
intertwin role patient payer provid
asset need holist provid benefit product
client think cost advantag underpin narrow
moat busi insur oper
benefit network effect believ help
provid barrier entri otherwis capital-light
believ moatworthi right
strateg addit express script help creat
synergi improv combin firm sell capabl
comprehens competit product
offer edg combin compani closer
creat
believ right strategi
compani pursu lack meaning
presenc patient-fac set versu provid
organ unit retail pharmaci
think combin medic pharmaceut benefit
program better posit firm compet
health insur asset repres eighth-largest
insur nation premium written appear
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
incumb plan enrol grow relationship
three entiti becom valuabl
patient plan negoti leverag expand either
premium becom rel afford plan
invest broader swath benefit member
greater
per-memb profit attract offer
either better price entic benefit
packag provid particip expand plan
network provid access greater patient volum key
compon profit busi high fix cost
short run dynam creat barrier entri
would-b competitor put togeth attract
price provid network new geographi prohibit
difficult without membership pool vice versa
firm newli acquir pbm asset also moatworthi
view larg due scale-deriv cost advantag
defin featur industri pbm
industri consolid top three player
control roughli script volum unit
state appear express script pois
fall number-thre posit lose largest
custom continu believ
asset like gener excess return time
core underpin narrow moat busi
fixed-cost leverag attain process
billion adjust script year
pbm abil consolid purchas power help
busi attain discount pharmaci drug
client final
relationship busi inher sticki anthem
asid normal percentag retent rate
high three player think weak switch cost
also help gener return clear would
enough support moat isol
think combin ripe
opportun captur synergi contend much
unit success past five year
gener cross-sel pharmaci benefit alongsid
medic insur busi think
opportun mimic strategi integr
differ price lever avail pull may
bit differ result like
ampl room firm lower target margin win
new busi drive above-market enrol growth
earn return combin compani cost capit
think underli sourc support
econom moat strengthen result strateg
reshap acquir express script industri
clearli made consciou decis move toward
stand-alon franchis believ consolid
translat improv econom profit gener
competit product offer ownership
give greater ownership combin cost
medic pharmaceut servic sell health
plan employ sponsor tie-up think cost
advantag like strengthen cigna
leverag combin platform reduc total benefit
expens member manag indic
nation account client exist
overlap third-parti pbm servic
allow substanti uptak come year
attempt transit exist client view
creat compel case strengthen
competit posit combin firm better equip
improv cost experi member year
think expand product scope
provid increment cost advantag stand-alon
pbm less convinc network effect
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
associ insur busi like
strengthen result combin dont believ
pbm industri tend build moatworthi network effect
isol patient retail pharmaci experi
much univers patient relationship
primari care specialti physician
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
recent merger express script give
sizabl pharmaci benefit presenc combin
medic benefit asset creat meaning cross-
sell cost-reduct opportun
omanag paid sizabl premium pharmaci
benefit platform cusp lose largest
custom open door potenti valu
destruct come year
oth firm sizabl medic insur busi
accumul scale necessari gener excess
cost
advantag network effect
oth compani presenc government-sponsor
plan medicar advantag medicaid
subscal grow membership
market rate last year
omanag suggest driven best-in-
class medic cost trend last six year
encourag continu enrol gain
opolici propos look curb chang use
rebat throughout system could creat disrupt
throughout suppli chain hinder pbm efficaci
profit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
financi condit remain manag
acquir express script manag capit
alloc decis need heavili scrutin
leverag fall sustain level pro
forma basi estim firm maintain gross
debt/adjust ebitda ratio approxim time
versu averag time histor manag
made progress goal redeem billion
debt princip current debt balanc stood
billion june billion
decemb assum compani repay anoth
billion put firm near
manag target gross leverag
debt/capit ratio less
given increas risk associ integr
express script loss largest custom
increas regulatori scrutini pbm profit give
high uncertainti rate strateg though
appreci benefit merger bring
organ own medic pharmaceut
benefit asset win strategi past
year think better posit win
busi larger pbm presenc howev think
loss largest custom pose
sizabl oper risk client transit express
servic late addit administr
focu lower prescript drug price could eventu
lower profit oper suppli chain
price busi model materi chang
uniqu expos dynam roughli
combin profit come legaci busi
final rhetor around healthcar reform like
intensifi elect season could
continu constrain stock passag
implement sweep chang remain remot
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
possibl think chang margin like
modif afford act continu
expans medicaid creat earli buy-in option
medicar wouldnt surpris see privat
insur play role improv coverag howev
sweep chang healthcar system -- particularli
medicar -- look like implement
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
repres date owner name posit common share held report holder issuer
new york mellon corp
share
fund
share
fund
think manag done adequ job
shepherd compani ever-chang
healthcar landscap acquisit
express script encourag manag
strategi abil carv narrow econom moat
busi give leadership standard mark
ceo david cordani led compani sinc
experi firm date back spent
time nearli firm major busi function
cordani overseen substanti valu creation firm
sinc global financi crisi applaud strategi
continu shift firm
healthcar arena away less moatworthi
ancillari insur oper capston effort
firm acquisit express script
lead independ pbm encourag
former express script ceo tim wentworth remain
busi presid pharmaci servic
divis help provid seamless
integr come month
along strong leadership team think board
creat reason well-structur incent scheme
align manag interest sharehold
short-term incent compens measur
adjust incom revenu oper expens target
along firm-wide strateg initi net
promot score improv employe engag
long-term award determin three-year rel
total sharehold return metric cumul adjust
incom measur period suggest
board consid replac adjust incom metric
return equiti return capit measur better
captur long-term perform instead reward
manag twice grow adjust incom
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
final major consider stewardship
methodolog pleas compani polici
separ board chairman ceo posit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
outlook manag includ risk
valuat attract across board aug
took detail look managed-car industri
came away confid posit outlook space
manag care remain attract industri
allow format sizabl econom moat
protect strong return capit almost everi corner
sector compani built advantag busi
model around monthli premium fee gener
recur revenu consolid past decad
allow competit remain ration despit
attract qualiti group trade modest discount
broader market reflect investor concern
futur healthcar polici regul unit
headlin domin variou democrat
parti polici propos medicar
would overhaul healthcar industri addit
manag care wrestl propos regulatori action
put forward trump administr so-
call rebat rule think medicar
function similar polici unlik next decad
administr abandon rebat rule earlier
year mark win industri valuat space
compress result heighten concern
market particip regard action think
investor long-term invest horizon stand
benefit own moatworthi firm favor
price integr servic offer unitedhealth
group make favorit among
five firm cover current trade discount
dcf-deriv fair valu estim
uncertainti like persist
gener elect cycl think group averag
valuat level roughli time earn emb
sizable-enough margin safeti warrant posit
detail analysi industri
assess potenti polici implic pleas see
risk manag creat opportun
moatworthi firm sizabl discount
growth share remain under-valued
post second-quart result broadli
consist expect back
earn contribut legaci pharmaci benefit
contract set expir end
year result dont anticip chang
fair valu estim believ share narrow-moat
firm trade cheapli roughli time
like first quarter medic enrol growth health
insur broadli disappoint strength within
commerci risk book off-set churn
government-sponsor fee-bas enrol left
overal membership roughli flat versu first quarter
led manag lower enrol expect
live year current guidanc impli roughli
membership growth enterpris compar
prior expect call growth nearer
firm consolid medic loss ratio came modestli
ahead expect consist full-
year estim manag intend broaden plan
offer geograph presenc within medicar
advantag upcom enrol period
help spur increment enrol growth
firm pharmaci benefit busi perform ahead
expect date segment higher revenu
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
earn outlook contribut manag
modestli higher full-year outlook firm-wide ep
portion benefit howev attribut cigna
insourc bulk pbm oper
histor farm optumrx action
set boost revenu script count segment
anticip gener materi earn
busi account roughli half improv
revenu outlook remaind driven better-than-
expect result core oper
first report juli axio trump administr
plan final propos rule alter flow
drug rebat purchas medicar part plan
rule would chang busi model
pharmaci benefit manag requir negoti
discount pass directli beneficiari
point sale rather use mechan lower
cost insur plan overal led ralli
pbms/insur distributor drug stock sank
investor wonder presid donald trump focu
turn next take rebat reform tabl put
pressur congress particularli bipartisan senat
financ committe team chuck grassley ron wyden
reveal drug-pric packag month stand
chanc pass chamber potenti reform
like reduc cost medicar patient also look
modest payer drug firm
think remain propos review
budget offic -- medicar part intern price
index -- unlik implement even final
congress power block rule judici review
could find massiv demonstr overextens
author center medicar medicaid
innov cmmi
altern expect senat drug price packag
could includ part reform also includ cap
out-of-pocket spend medicar part anticip
propos would see widespread support
policymak result higher likelihood
success think chang would manag
drug firm effect achiev bipartisan
polici goal lower healthcar cost american
addit detail analysi effect
rebat rule elimin pleas see report rebat
consist strong start
narrow-moat report first-quart result
track line full-year expect dont
anticip alter fair valu estim believ
share look attract trade time current
adjust earn forecast howev given
on-going integr express script loss
pharmaci benefit busi emphas
high uncertainti rate name
effect integr segment reclassif
firm disclosur make insight year-
over-year comparison combin express
script busi fairli difficult think perform
quarter overal profit
exclud surpass expect although
roughli half excess attribut favor
prior-year develop firm medic cost reserv
figur account manag rais guidanc
outlook slightli full year legaci firm
larg met expect revenu adjust
profit exclud contribut
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
medic enrol growth disappoint
figur view bulk compani
membership show littl improv versu end
commerci risk book respect
sequenti improv remaind firm
product segment show growth next
quarter meet manag target
net member addit year
strategi remain track oper cash flow larg
alloc toward billion debt repay
million share repurchas given stock discount
valuat applaud balanc effort right-siz
compani capit structur remain path
achiev debt-to-capit ratio high rang
end
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
